ExpandLiraglutide and Insulin Prescriptions Associated with Increased Likelihood of Rare Vision Loss
Patients with type 2 diabetes who are prescribed liraglutide have a 179% higher likelihood of developing non-arteritic anterior ischemic optic neuropathy (NAION), while those prescribed insulin have an 86% greater likelihood compared to patients who were prescribed other diabetes medications. No significant association was found between semaglutide or dulaglutide and NAION.


















